The Allegations: Robbins LLP is Investigating Allegations that Humana, Inc. (HUM) Misled Investors Regarding its Business Prospects What Now: You may be eligible to participate in the class action against Humana, Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by August 2, 2024. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible f ...

To join the Humana class action, go to https://rosenlegal.com/submit-form/?case_id=25679 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- SO WHAT: If you purchased Humana common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHY ROSEN LAW: We encourage investors to select qualified counsel ...

NEW YORK, June 7, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Humana Inc. ("Humana" or the "Company") (NYSE: HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. On June 13, 2023, UnitedHealth Group Inc. ("UnitedHealth"), one of Humana's prima ...

If you purchased Humana common stock between July 27, 2022 and January 24, 2024, and suffered substantial losses, and you wish to obtain additional information or serve as lead plaintiff in this lawsuit, you may submit your information and contact us here: https://dicellolevitt.com/securities/humana/. No Case Has Been Filed and No Class Has Been Certified. Until a case is filed and a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. The Huma ...

NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Humana Inc. ("Humana" or the "Company") (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. On this news, Humana's stock price fell $18.20 per share, or almost 4%, t ...

NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Humana Inc. ("Humana" or the "Company") (NYSE: HUM) in the United States District Court for the District of Delaware on behalf of all persons and entities who purchased or otherwise acquired Humana common stock between July 27, 2022, and January 24, 2024, both dates inclusive (the "Class Period"). Investors have until Augus ...

NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Delaware on behalf of all persons and entities who purchased securities of Humana Inc. ("Humana" or the "Company") (NYSE: HUM) between July 27, 2022 and January 24, 2024, inclusive (the "Class Period"). Then, on June 16, 2023, the Complaint alleges that Humana reported "higher than anticipated non-inpatient utilization t ...

文章核心观点 - 该公司与阿拉巴马大学伯明翰分校(UAB)医疗系统达成网络协议,为公司的Medicare Advantage会员提供更多医疗服务选择 [1][2][3] - 这一合作有助于公司在阿拉巴马州扩大覆盖范围,增加会员数量,从而带来更高的保费收入 [3][4][5] - 公司积极与当地医疗服务提供商合作,以扩大本地医疗网络,更好地服务于各地的会员 [5][6] 公司概况 - 公司Medicare业务覆盖广泛,截至2024年3月31日,共有约840万Medicare客户,其中个人Medicare Advantage会员约550万 [5] - 公司股价在过去3个月内上涨7.8%,优于同行业3.2%的涨幅 [7] 行业动态 - 公司积极整合各种有利特征到自身的保险计划中 [5] - 同行业公司Bioventus、Alcon和Encompass Health近期股价也有不同程度的上涨 [13]

LOS ANGELES, June 4, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Humana Inc. ("Humana" or "the Company") (NYSE: HUM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2022 and January 24, 2024, inclusive (the "Class Period"), are encourag ...

文章核心观点 - 该文章描述了针对Humana公司的一起集体诉讼案件 [1][3][4] - 该诉讼指控Humana公司及其高管在2022年7月27日至2024年1月24日期间做出了虚假和/或误导性陈述,隐瞒了医疗成本上升给公司调整后每股收益带来的压力 [4] - 根据诉讼,Humana公司在2023年6月13日和6月16日发布的消息显示,医疗服务利用率和成本超出预期,导致其股价下跌 [5][6] - 诉讼还指控Humana公司在2024年1月18日和1月25日发布的消息显示,医疗费用率上升和预计2024年医疗成本将持续高企,导致其股价大幅下跌 [7][8] 行业总结 - Humana是一家医疗保险公司,为会员提供医疗福利计划 [3] - 该诉讼指控Humana公司在疫情影响减弱后,医疗服务需求激增,但公司未能充分披露这一情况对其业绩的负面影响 [4] - 根据诉讼,Humana公司的主要竞争对手UnitedHealth Group也表示看到门诊服务活动水平上升,反映出行业普遍面临的挑战 [5] 公司总结 - Humana公司在2023年第四季度和全年的医疗费用率大幅上升,导致每股亏损4.42美元 [7][8] - Humana公司预计2024年医疗成本高企的情况将持续 [8] - 该诉讼指控Humana公司及其高管在上述期间做出了虚假和/或误导性陈述,隐瞒了医疗成本上升对其业绩的负面影响 [4]